Literature DB >> 7614070

Bronchial epithelial cell-cytokine interactions in airway inflammation.

S J Levine1.   

Abstract

A variety of cytokine bronchial cell interactions may play an important role in normal host defense as well as in the pathogenesis of inflammatory airway disorders such as asthma, cystic fibrosis, acute and chronic bronchitis, and bronchiectasis. First, airway epithelial cells may participate in local cytokine networks by synthesizing interleukins, chemokines, colony stimulating factors and growth factors in response to inflammatory mediators. Bronchial epithelial cell derived cytokines may thereby amplify ongoing inflammatory processes via the recruitment and activation of specific subsets of inflammatory cells, as well as by prolonging their survival in the airway microenvironment. Second, airway epithelial cells can initiate inflammatory cascades by generating cytokines in direct response to viral and bacterial products, noxious gases, and sensitizing chemicals. Third, airway epithelial cells represent targets for paracrine acting cytokines, which may then modulate bronchial epithelial cell functions. Finally, airway epithelial cells may modulate ongoing inflammatory events in the airway microenvironment via the shedding of soluble TNF receptors. Cytokine-bronchial epithelial cell interactions represent an important mechanism by which inflammatory events in the airway microenvironment can be regulated and represent potential targets for novel anti-inflammatory therapies in airway disorders.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7614070

Source DB:  PubMed          Journal:  J Investig Med        ISSN: 1081-5589            Impact factor:   2.895


  25 in total

1.  Induction of proinflammatory cytokines in human lung epithelial cells during Chlamydia pneumoniae infection.

Authors:  Jun Yang; W Craig Hooper; Donald J Phillips; Maria L Tondella; Deborah F Talkington
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

2.  Anti-Inflammatory Effect of Apigenin on LPS-Induced Pro-Inflammatory Mediators and AP-1 Factors in Human Lung Epithelial Cells.

Authors:  Rajeshwari H Patil; R L Babu; M Naveen Kumar; K M Kiran Kumar; Shubha M Hegde; Rashmi Nagesh; Govindarajan T Ramesh; S Chidananda Sharma
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

3.  Apigenin inhibits PMA-induced expression of pro-inflammatory cytokines and AP-1 factors in A549 cells.

Authors:  Rajeshwari H Patil; R L Babu; M Naveen Kumar; K M Kiran Kumar; Shubha M Hegde; Govindarajan T Ramesh; S Chidananda Sharma
Journal:  Mol Cell Biochem       Date:  2015-02-10       Impact factor: 3.396

4.  Aldose reductase inhibition suppresses the expression of Th2 cytokines and airway inflammation in ovalbumin-induced asthma in mice.

Authors:  Umesh C S Yadav; Amarjit S Naura; Leopoldo Aguilera-Aguirre; Kota V Ramana; Istvan Boldogh; Sanjiv Sur; Hamid A Boulares; Satish K Srivastava
Journal:  J Immunol       Date:  2009-09-14       Impact factor: 5.422

5.  Muc1 cell surface mucin attenuates epithelial inflammation in response to a common mucosal pathogen.

Authors:  Wei Guang; Hua Ding; Steven J Czinn; K Chul Kim; Thomas G Blanchard; Erik P Lillehoj
Journal:  J Biol Chem       Date:  2010-04-29       Impact factor: 5.157

6.  Intratracheal bleomycin causes airway remodeling and airflow obstruction in mice.

Authors:  Vasiliy V Polosukhin; Amber L Degryse; Dawn C Newcomb; Brittany R Jones; Lorraine B Ware; Jae Woo Lee; James E Loyd; Timothy S Blackwell; William E Lawson
Journal:  Exp Lung Res       Date:  2012-04       Impact factor: 2.459

7.  Role of defensins in the pathogenesis of chronic lung allograft rejection.

Authors:  Venkataswarup Tiriveedhi; Babak Banan; Saini Deepti; Angaswamy Nataraju; Ramsey Hachem; Elbert Trulock; Patterson G Alexander; Mohanakumar Thalachallour
Journal:  Hum Immunol       Date:  2013-12-28       Impact factor: 2.850

8.  Ligand-induced differentiation of glucocorticoid receptor (GR) trans-repression and transactivation: preferential targetting of NF-kappaB and lack of I-kappaB involvement.

Authors:  I M Adcock; Y Nasuhara; D A Stevens; P J Barnes
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

9.  Glucocorticoids decrease c-fos expression in human nasal polyps in vivo.

Authors:  J N Baraniuk; G Wong; M Ali; M Sabol; T Troost
Journal:  Thorax       Date:  1998-07       Impact factor: 9.139

10.  Anti-inflammatory, immunomodulatory, and heme oxygenase-1 inhibitory activities of ravan napas, a formulation of uighur traditional medicine, in a rat model of allergic asthma.

Authors:  Sajida Abdureyim; Nurmuhammat Amat; Anwar Umar; Halmurat Upur; Benedicte Berke; Nicholas Moore
Journal:  Evid Based Complement Alternat Med       Date:  2010-10-05       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.